Status:

COMPLETED

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Lead Sponsor:

AB Science

Conditions:

Alzheimer Disease

Eligibility:

All Genders

50+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to assess the safety and efficacy of masitinib for the treatment of mild to moderate Alzheimer's Disease. Masitinib will be administered as add-on therapy in patients who ...

Detailed Description

Actual standard treatment for mild to moderately severe Alzheimer's dementia includes acetylcholinesterase inhibitors (donepezil, rivastigmine and galantamine) and a NMDA receptor antagonist (memantin...

Eligibility Criteria

Inclusion

  • Inclusion criteria include:
  • Patient with dementia of Alzheimer's type, according to the Diagnostic and Statistical Manual of Mental Disorders criteria (DSM-IV)
  • Patient with probable Alzheimer' disease according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association criteria (NINCDS-ADRDA)
  • Patient with MMSE ≥ 12 and ≤ 25 at baseline
  • Patient treated for a minimum of 6 months with a stable dose of cholinesterase inhibitors (donepezil, rivastigmine or galantamine) at baseline, and/or a stable dose of memantine for a minimum of 6 months at baseline, with no changes foreseen in therapy throughout the study.
  • Exclusion criteria include:
  • Patient with any other cause of dementia not due to Alzheimer's disease.
  • Patient with Alzheimer disease with severe forms of delusions or delirium (patients with light and mild forms of delusions and delirium will be allowed in the study).

Exclusion

    Key Trial Info

    Start Date :

    January 1 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2020

    Estimated Enrollment :

    721 Patients enrolled

    Trial Details

    Trial ID

    NCT01872598

    Start Date

    January 1 2012

    End Date

    December 1 2020

    Last Update

    September 29 2023

    Active Locations (6)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (6 locations)

    1

    MHAT Sveta Marina

    Varna, Bulgaria, 9010

    2

    General Hospital of Thessaloniki

    Thessaloniki, Greece, 570 10

    3

    Centrum Zdrowia Stołeczna 7

    Bialystok, Poland, 15-879

    4

    Spitalul Universitar de Urgenta Elias

    Bucharest, Romania, 013686